FMP

FMP

Enter

DNAY - Codex DNA, Inc.

Financial Summary of Codex DNA, Inc.(DNAY), Codex DNA, Inc., a synthetic biology company, manufactures and sells synthetic biology instruments,

photo-url-https://financialmodelingprep.com/image-stock/DNAY.png

Codex DNA, Inc.

DNAY

NASDAQ

Inactive Equity

Codex DNA, Inc., a synthetic biology company, manufactures and sells synthetic biology instruments, reagents, and associated products and related services, primarily to pharmaceutical and academic laboratories worldwide. Its solutions include BioXp system that empowers researchers to go from a digital DNA sequence to endpoint-ready synthetic DNA; BioXp portal, an online portal that offers an intuitive guided workflow and design tools for building new DNA sequences and assembling them into vectors of choice; BioXp kits that contain building blocks and reagents, including its Gibson Assembly branded reagents, for specific synthetic biology workflow applications; Cloud-based scripts; Benchtop reagents that contain all the reagents necessary to proceed with a specific synthetic biology workflow on the benchtop using products generated on the BioXp system; Biofoundry Services, which enable a customer to order and receive the BioXp system endpoint-ready products, such as genes, clones, cell-free amplified DNA, and variant libraries; and short oligo ligation assembly enzymatic DNA synthesis. It also serves government institutions, contract research organizations, and synthetic biology companies. The company was formerly known as SGI-DNA, Inc. and changed its name to Codex DNA, Inc. in March 2020. Codex DNA, Inc. was incorporated in 2011 and is headquartered in San Diego, California.

1.3 USD

0.1 (7.69%)

About

ceo

Dr. Todd R. Nelson MBA, Ph.D.

sector

Healthcare

industry

Medical - Devices

website

https://codexdna.com

exchange

NASDAQ

Description

Codex DNA, Inc., a synthetic biology company, manufactures and sells synthetic biology instruments, reagents, and associated products and related services, primarily to pharmaceutical and academic laboratories worldwide. Its solutions include BioXp system that empowers researchers to go from a digital DNA sequence to endpoint-ready synthetic DNA; BioXp portal, an online portal that offers an intuitive guided workflow and design tools for building new DNA sequences and assembling them into vectors of choice; BioXp kits that contain building blocks and reagents, including its Gibson Assembly branded reagents, for specific synthetic biology workflow applications; Cloud-based scripts; Benchtop r...

CIK

0001850079

ISIN

US1920031010

CUSIP

192003101

Address

9535 Waples Street

Phone

858 228 4115

Country

US

Employee

212

IPO Date

Jun 18, 2021

Summary

CIK

0001850079

Exchange

NASDAQ

Industry

Medical - Devices

Sector

Healthcare

CUSIP

192003101

ISIN

US1920031010

Country

US

Price

1.3

Beta

0

Volume Avg.

79.4k

Market Cap

38.32M

Shares

-

52-Week

1.0801-11.02

DCF

0

ROE

-

ROA

-

Operating Margin

-

Debt/Equity

-

P/E

0

P/B

-

Website

https://codexdna.com

Historical Prices

We are unable to load the chart at this time.

fmp-logo

Financial Statement

We are unable to load the chart at this time.

fmp-logo

Earnings

We are unable to load the chart at this time.

fmp-logo

Upgrades and Downgrades

We are unable to load this data!

fmp-logo

People Also Watch

page loading card

Latest DNAY News

It looks like there's no news available.

fmp-logo
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep